{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:55:23Z","timestamp":1781643323012,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007465","name":"UiT The Arctic University of Norway","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007465","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Organized mammographic screening has been shown to reduce breast cancer mortality across numerous high-quality studies. However, advancements in treatment, changes in screening techniques and adherence might alter the mortality reduction. In this study, we used data from an organized breast cancer screening program that started 30\u00a0years ago to investigate breast cancer mortality among women who were invited and attended the program (screened) versus women who were invited, but who did not attend (unscreened).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included information on invitation to and attendance in BreastScreen Norway, breast cancer diagnosis, emigration, death, and cause of death for women residing in Norway between January 1, 1996, and December 31, 2023. A total of 1,192,148 women aged 50\u201369\u00a0years without diagnosis of breast cancer at first invitation to screening and inclusion in the study were followed until breast cancer death, death of other causes, emigration or end of follow-up. We applied a Poisson regression model to compare incidence-based breast cancer mortality rate ratios (MRR) with 95% confidence intervals (CI) between screened and unscreened women invited to attend the program, adjusting for age, calendar year, time since cohort entry, and self-selection bias using correction coefficients based on Norwegian data, and a coefficient proposed by Duffy in 2002.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The screened cohort comprised 14,223,189 women-years, while the unscreened cohort accounted for 2,474,340 women-years. The crude breast cancer mortality rate was 28.2 per 100,000 women-years in the screened cohort, compared to 51.2 per 100,000 women-years in the unscreened cohort. The resulting unadjusted mortality rate ratio (MRR) was 0.55 (95% CI: 0.52\u20130.59). After adjusting for self-selection bias, the MRR remained strongly in favor of attending screening, and varied from 0.49 (95%CI 0.46\u20130.53) to 0.71 (95% CI: 0.66\u20130.76) when using self-selection bias correction coefficients derived from Norwegian data and was 0.61 (95% CI: 0.56\u20130.65) when using the coefficient provided by Duffy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>After 27\u00a0years of follow-up, breast cancer mortality was 30\u201350% lower for invited and screened women compared to invited but unscreened women in BreastScreen Norway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-026-02244-5","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T05:51:34Z","timestamp":1773726694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Breast cancer mortality among women who have attended BreastScreen Norway, 1996\u20132023"],"prefix":"10.1186","volume":"28","author":[{"given":"Nataliia","family":"Moshina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Gjesvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marthe","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giske","family":"Ursin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solveig","family":"Hofvind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"4","key":"2244_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778\u201389.","journal-title":"Int J Cancer"},{"issue":"4","key":"2244_CR2","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3390\/cancers12040976","volume":"12","author":"A Dibden","year":"2020","unstructured":"Dibden A, et al. Worldwide review and meta-analysis of cohort studies measuring the effect of mammography screening programmes on incidence-based breast cancer mortality. Cancers (Basel). 2020;12(4):976.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"2244_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/jnci\/djz220","volume":"112","author":"S Sebu\u00f8deg\u00e5rd","year":"2020","unstructured":"Sebu\u00f8deg\u00e5rd S, Botteri E, Hofvind S. Breast cancer mortality after implementation of organized population-based breast cancer screening in Norway. J Natl Cancer Inst. 2020;112(8):839\u201346.","journal-title":"J Natl Cancer Inst"},{"key":"2244_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g3701","author":"H Weedon-Fekj\u00e6r","year":"2014","unstructured":"Weedon-Fekj\u00e6r H, Romundstad PR, Vatten LJ. Modern mammography screening and breast cancer mortality: population study. BMJ. 2014. https:\/\/doi.org\/10.1136\/bmj.g3701.","journal-title":"BMJ"},{"issue":"2","key":"2244_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1001\/jama.2017.19130","volume":"319","author":"SK Plevritis","year":"2018","unstructured":"Plevritis SK, et al. Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000\u20132012. JAMA. 2018;319(2):154\u201364.","journal-title":"JAMA"},{"key":"2244_CR6","doi-asserted-by":"publisher","first-page":"d4411","DOI":"10.1136\/bmj.d4411","volume":"343","author":"P Autier","year":"2011","unstructured":"Autier P, et al. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ. 2011;343:d4411.","journal-title":"BMJ"},{"issue":"3","key":"2244_CR7","doi-asserted-by":"publisher","first-page":"e017806","DOI":"10.1136\/bmjopen-2017-017806","volume":"8","author":"C Herrmann","year":"2018","unstructured":"Herrmann C, et al. Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies. BMJ Open. 2018;8(3):e017806.","journal-title":"BMJ Open"},{"issue":"3","key":"2244_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1001\/jama.2023.25881","volume":"331","author":"JL Caswell-Jin","year":"2024","unstructured":"Caswell-Jin JL, et al. Analysis of breast cancer mortality in the US\u20141975 to 2019. JAMA. 2024;331(3):233\u201341.","journal-title":"JAMA"},{"key":"2244_CR9","unstructured":"European Commission. Cancer screening, diagnosis and care. European quality assurance scheme for breast cancer services. 2024. Available from: https:\/\/cancer-screening-and-care.jrc.ec.europa.eu\/en\/ecibc\/breast-quality-assurance-scheme."},{"key":"2244_CR10","doi-asserted-by":"publisher","first-page":"111426","DOI":"10.1016\/j.jclinepi.2024.111426","volume":"172","author":"P Autier","year":"2024","unstructured":"Autier P, et al. Effect of screening mammography on the risk of breast cancer deaths and of all-cause deaths: a systematic review with meta-analysis of cohort studies. J Clin Epidemiol. 2024;172:111426.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"2244_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7326\/M15-0969","volume":"164","author":"HD Nelson","year":"2016","unstructured":"Nelson HD, et al. Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. preventive services task force recommendation. Ann Intern Med. 2016;164(4):244\u201355.","journal-title":"Ann Intern Med"},{"issue":"3","key":"2244_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1158\/1055-9965.EPI-15-0803","volume":"25","author":"NJ Massat","year":"2016","unstructured":"Massat NJ, et al. Impact of screening on breast cancer mortality: the UK program 20 years on. Cancer Epidemiol Biomark Prev. 2016;25(3):455\u201362.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"2244_CR13","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41416-020-01163-2","volume":"124","author":"R Maroni","year":"2021","unstructured":"Maroni R, et al. A case-control study to evaluate the impact of the breast screening programme on mortality in England. Br J Cancer. 2021;124(4):736\u201343.","journal-title":"Br J Cancer"},{"issue":"17","key":"2244_CR14","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1002\/cncr.28174","volume":"119","author":"S Hofvind","year":"2013","unstructured":"Hofvind S, et al. Breast cancer mortality in participants of the Norwegian breast cancer screening program. Cancer. 2013;119(17):3106\u201312.","journal-title":"Cancer"},{"issue":"5","key":"2244_CR15","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1007\/s00330-020-07340-4","volume":"31","author":"KM Tsuruda","year":"2021","unstructured":"Tsuruda KM, et al. Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological review. Eur Radiol. 2021;31(5):2677\u201386.","journal-title":"Eur Radiol"},{"issue":"2","key":"2244_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/1467-9876.00266","volume":"51","author":"SW Duffy","year":"2002","unstructured":"Duffy SW, et al. Correcting for non-compliance bias in case\u2013control studies to evaluate cancer screening programmes. J R Stat Soc Ser C Appl Stat. 2002;51(2):235\u201343.","journal-title":"J R Stat Soc Ser C Appl Stat"},{"key":"2244_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2147\/CLEP.S515464","volume":"17","author":"P Autier","year":"2025","unstructured":"Autier P. Self-selection bias in randomized and observational studies on screening mammography: a quantitative assessment. Clin Epidemiol. 2025;17:441\u201350.","journal-title":"Clin Epidemiol"},{"issue":"7","key":"2244_CR18","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1158\/1055-9965.EPI-21-1386","volume":"31","author":"L McWilliams","year":"2022","unstructured":"McWilliams L, et al. The impact of morbidity and disability on attendance at organized breast cancer-screening programs: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2022;31(7):1275\u201383.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2244_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.canep.2016.12.010","volume":"47","author":"A Diaz","year":"2017","unstructured":"Diaz A, et al. Association between comorbidity and participation in breast and cervical cancer screening: a systematic review and meta-analysis. Cancer Epidemiol. 2017;47:7\u201319.","journal-title":"Cancer Epidemiol"},{"issue":"11","key":"2244_CR20","doi-asserted-by":"publisher","first-page":"e046660","DOI":"10.1136\/bmjopen-2020-046660","volume":"11","author":"R Mottram","year":"2021","unstructured":"Mottram R, et al. Factors associated with attendance at screening for breast cancer: a systematic review and meta-analysis. BMJ Open. 2021;11(11):e046660.","journal-title":"BMJ Open"},{"key":"2244_CR21","volume-title":"BreastScreen Norway: 25 years of organized screening","author":"EW Bj\u00f8rnson","year":"2022","unstructured":"Bj\u00f8rnson EW, et al. BreastScreen Norway: 25 years of organized screening. Oslo: Cancer Registry of Norway; 2022."},{"issue":"7","key":"2244_CR22","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.ejca.2008.10.037","volume":"45","author":"IK Larsen","year":"2009","unstructured":"Larsen IK, et al. Data quality at the cancer registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009;45(7):1218\u201331.","journal-title":"Eur J Cancer"},{"key":"2244_CR23","unstructured":"Norwegian Institute of Public Health. Cancer registry of Norway. Screening about the national screening programmes. 2024. Available from: https:\/\/www.kreftregisteret.no\/en\/screening\/About-the-Screening-Programmes\/."},{"key":"2244_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD","author":"E von Elm","year":"2007","unstructured":"von Elm E, et al. The Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. The Lancet. 2007. https:\/\/doi.org\/10.1136\/bmj.39335.541782.AD.","journal-title":"The Lancet"},{"issue":"2","key":"2244_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/0969141320950776","volume":"28","author":"N Dunn","year":"2021","unstructured":"Dunn N, et al. Breast-cancer mortality in screened versus unscreened women: long-term results from a population-based study in Queensland, Australia. J Med Screen. 2021;28(2):193\u20139.","journal-title":"J Med Screen"},{"issue":"2","key":"2244_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10389-018-0937-1","volume":"27","author":"M Le","year":"2019","unstructured":"Le M, et al. Lower attendance rates in BreastScreen Norway among immigrants across all levels of socio-demographic factors: a population-based study. J Public Health. 2019;27(2):229\u201340.","journal-title":"J Public Health"},{"issue":"10","key":"2244_CR27","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/jnci\/djaa025","volume":"112","author":"MJ Yaffe","year":"2020","unstructured":"Yaffe MJ, Mainprize JG. The value of all-cause mortality as a metric for assessing breast cancer screening. J Natl Cancer Inst. 2020;112(10):989\u201393.","journal-title":"J Natl Cancer Inst"},{"key":"2244_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv298","author":"E Senkus","year":"2015","unstructured":"Senkus E, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015. https:\/\/doi.org\/10.1093\/annonc\/mdv298.","journal-title":"Ann Oncol"},{"key":"2244_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2018.04.009","volume":"99","author":"MGM Derks","year":"2018","unstructured":"Derks MGM, et al. Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial. Eur J Cancer. 2018;99:1\u20138.","journal-title":"Eur J Cancer"},{"issue":"3","key":"2244_CR30","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.18632\/aging.203881","volume":"14","author":"A Nasrazadani","year":"2022","unstructured":"Nasrazadani A, et al. Breast cancer mortality as a function of age. Aging (Albany NY). 2022;14(3):1186\u201399.","journal-title":"Aging (Albany NY)"},{"key":"2244_CR31","unstructured":"Cancer in Norway 2024\u2014cancer incidence, mortality, survival and prevalence in Norway. 2025, Cancer Registry of Norway. Norwegian Institute of Public Health: Oslo: Cancer Registry of Norway."},{"key":"2244_CR32","unstructured":"NORDCAN. Association of the Nordic cancer registries. Age-specific. 2024 [cited 2024 April 11]; Available from: https:\/\/nordcan.iarc.fr\/en\/dataviz\/age_specific?mode=cancer&group_populations=1&multiple_cancers=1&types=0&sexes=2&populations=578&cancers=180&age_start=10&age_end=16&years=1980_1985&group_years=1&key=age_specific_rate&years_available=1943_2021."},{"issue":"4","key":"2244_CR33","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1097\/AS9.0000000000000205","volume":"3","author":"P Christiansen","year":"2022","unstructured":"Christiansen P, et al. Breast-conserving surgery or mastectomy? Impact on survival. Ann Surg Open. 2022;3(4):e205.","journal-title":"Ann Surg Open"},{"issue":"3","key":"2244_CR34","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1148\/radiol.2021203935","volume":"299","author":"SW Duffy","year":"2021","unstructured":"Duffy SW, et al. Beneficial effect of consecutive screening mammography examinations on mortality from breast cancer: a prospective study. Radiology. 2021;299(3):541\u20137.","journal-title":"Radiology"},{"key":"2244_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17101641","author":"HF Ribeiro","year":"2025","unstructured":"Ribeiro HF, et al. Racial and socioeconomic disparity in breast cancer mortality: a systematic review and meta-analysis. Cancers (Basel). 2025. https:\/\/doi.org\/10.3390\/cancers17101641.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"2244_CR36","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1002\/ijc.31729","volume":"143","author":"H Th\u00f8gersen","year":"2018","unstructured":"Th\u00f8gersen H, et al. Differences in cancer survival between immigrants in Norway and the host population. Int J Cancer. 2018;143(12):3097\u2013105.","journal-title":"Int J Cancer"},{"key":"2244_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/978-3-319-16366-6_11","volume-title":"Improving outcomes for breast cancer survivors: perspectives on research challenges and opportunities","author":"C-C Hong","year":"2015","unstructured":"Hong C-C, Ambrosone CB, Goodwin PJ. Comorbidities and their management: potential impact on breast cancer outcomes. In: Ganz PA, editor. Improving outcomes for breast cancer survivors: perspectives on research challenges and opportunities. Cham: Springer International Publishing; 2015. p. 155\u201375."},{"issue":"11","key":"2244_CR38","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1002\/ijc.35312","volume":"156","author":"E Lund","year":"2025","unstructured":"Lund E, Busund LR, Holden L. Curvilinear incidence models for parity in the entire fertility range for cancers of the breast, ovary, and endometrium: a follow-up of the Norwegian 1960 census. Int J Cancer. 2025;156(11):2118\u201326.","journal-title":"Int J Cancer"},{"key":"2244_CR39","doi-asserted-by":"publisher","first-page":"e085029","DOI":"10.1136\/bmj-2025-085029","volume":"390","author":"Z Ma","year":"2025","unstructured":"Ma Z, et al. First mammography screening participation and breast cancer incidence and mortality in the subsequent 25 years: population based cohort study. BMJ. 2025;390:e085029.","journal-title":"BMJ"},{"issue":"5","key":"2244_CR40","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/eurpub\/ckw070","volume":"26","author":"A Lundqvist","year":"2016","unstructured":"Lundqvist A, et al. Socioeconomic inequalities in breast cancer incidence and mortality in Europe-a systematic review and meta-analysis. Eur J Public Health. 2016;26(5):804\u201313.","journal-title":"Eur J Public Health"},{"key":"2244_CR41","unstructured":"Statistics Denmark. Indvandrere har lavere d\u00f8delighed end danskere [Immigrants have lower mortality than Danish people]. 2010; Available from: https:\/\/www.dst.dk\/da\/Statistik\/nyheder-analyser-publ\/bagtal\/2010\/2010-11-30-Indvandreresdoedelighed."},{"issue":"1","key":"2244_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/00324728.2021.1887506","volume":"76","author":"M Jalovaara","year":"2022","unstructured":"Jalovaara M, Andersson L, Miettinen A. Parity disparity: educational differences in Nordic fertility across parities and number of reproductive partners. Popul Stud. 2022;76(1):119\u201336.","journal-title":"Popul Stud"},{"issue":"4","key":"2244_CR43","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/aogs.14067","volume":"100","author":"KS Maeland","year":"2021","unstructured":"Maeland KS, et al. Placental abruption in immigrant women in Norway: a population-based study. Acta Obstet Gynecol Scand. 2021;100(4):658\u201365.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"13","key":"2244_CR44","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.1002\/cam4.2476","volume":"8","author":"EAM Heijnsdijk","year":"2019","unstructured":"Heijnsdijk EAM, et al. All-cause mortality versus cancer-specific mortality as outcome in cancer screening trials: a review and modeling study. Cancer Med. 2019;8(13):6127\u201338.","journal-title":"Cancer Med"},{"key":"2244_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ejca.2019.12.010","volume":"127","author":"N Zielonke","year":"2020","unstructured":"Zielonke N, et al. Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: a systematic review. Eur J Cancer. 2020;127:191\u2013206.","journal-title":"Eur J Cancer"},{"issue":"1","key":"2244_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1258\/jms.2012.012082","volume":"19","author":"D Puliti","year":"2012","unstructured":"Puliti D, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen. 2012;19(1):42\u201356.","journal-title":"J Med Screen"},{"issue":"3","key":"2244_CR47","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ijc.28052","volume":"133","author":"RS Falk","year":"2013","unstructured":"Falk RS, et al. Overdiagnosis among women attending a population-based mammography screening program. Int J Cancer. 2013;133(3):705\u201312.","journal-title":"Int J Cancer"},{"issue":"6","key":"2244_CR48","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.canep.2015.08.013","volume":"39","author":"A Seigneurin","year":"2015","unstructured":"Seigneurin A, et al. Overdiagnosis associated with breast cancer screening: a simulation study to compare lead-time adjustment methods. Cancer Epidemiol. 2015;39(6):1128\u201335.","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"2244_CR49","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3109\/02841869609083997","volume":"35","author":"JP Garne","year":"1996","unstructured":"Garne JP, Aspegren K, Balldin G. Breast cancer as cause of death--a study over the validity of the officially registered cause of death in 2631 breast cancer patients dying in Malm\u00f6, Sweden 1964\u20131992. Acta Oncol. 1996;35(6):671\u20135.","journal-title":"Acta Oncol"},{"issue":"2","key":"2244_CR50","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/21681805.2017.1421260","volume":"52","author":"S L\u00f6ffeler","year":"2018","unstructured":"L\u00f6ffeler S, et al. High Norwegian prostate cancer mortality: evidence of over-reporting. Scand J Urol. 2018;52(2):122\u20138.","journal-title":"Scand J Urol"},{"issue":"8","key":"2244_CR51","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/annonc\/mdg322","volume":"14","author":"SW Duffy","year":"2003","unstructured":"Duffy SW, et al. The Swedish two-county trial of mammographic screening: cluster randomisation and end point evaluation. Ann Oncol. 2003;14(8):1196\u20138.","journal-title":"Ann Oncol"},{"key":"2244_CR52","unstructured":"Lov om behandling av Personopplysninger (Personopplysningsloven) Europaparlaments- og r\u00e5dsforordning (EU) 2016\/679 (Generell Personvernforordning) Kapittel II Artikkel 6 [Act on the processing of personal data (Personal Data Act) European parliament and council reguslation (EU) 2016\/679 (General data protection regulation) chapter II article 6]. 2016."},{"key":"2244_CR53","unstructured":"Forskrift om innsamling og behandling av helseopplysninger i Kreftregisteret (Kreftregisterforskriften) [Regulations on the collection and processing of health information in the cancer registry (Cancer Registry Regulations)]. 2001; Available from: https:\/\/lovdata.no\/dokument\/SF\/forskrift\/2001-12-21-1477"},{"key":"2244_CR54","unstructured":"Act of 18 May 2001 No. 24 on Personal health data filing systems and the processing of personal health data (Personal Health Data Filing System Act): section 11. 2001."}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02244-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02244-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02244-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:16:05Z","timestamp":1781640965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02244-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2244"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02244-5","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has a legal basis in accordance with Articles 6 (1) (e) and 9 (2) (j) of the General Data Protection Regulation (GDPR) [\n                      \n                      ]. Exemption from confidentiality as decided by Helsedataservice constitutes the necessary supplementary legal basis pursuant by GDPR Article 6 (e).The use of data was approved by the Regional Committee for Medical and Health Research Ethics (REC #510838). The data were disclosed with a legal basis in the Cancer Registry Regulations section 3-1 [\n                      \n                      ] the Personal Health Data Filing System Act section 19 a to 19 h [\n                      \n                      ].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors disclosed no relevant relationships.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}